Scinai Immunotherapeutics Ltd SCNI Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.75 down $0.15, 16.54% at close Oct 16
Last close · Previous close $0.90
- Market cap
- At the Oct 16 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.75down $0.15, 16.54%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.90Oct 15
- Volume225.22KOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume4.09MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.73 to $15.50; now $0.75
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
SCNI trailed the S&P 500 in all 7 periods.
| Period | SCNI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SCNI: down 50.5% S&P 500: up 1.5% | SCNI trailed the S&P 500 by 52.0 percentage points Trailed |
| 3M | SCNI: down 70.4% S&P 500: up 1.9% | SCNI trailed the S&P 500 by 72.3 percentage points Trailed |
| YTD | SCNI: down 89.4% S&P 500: up 12.8% | SCNI trailed the S&P 500 by 102.2 percentage points Trailed |
| 1Y | SCNI: down 94.8% S&P 500: up 16.8% | SCNI trailed the S&P 500 by 111.6 percentage points Trailed |
| Long term | ||
| 3Y | SCNI: down 99.0% S&P 500: up 81.5% −78.3% vs +22.0% a year | SCNI trailed the S&P 500 by 180.5 percentage points Trailed |
| 5Y | SCNI: down 100.0% S&P 500: up 83.1% −79.8% vs +12.9% a year | SCNI trailed the S&P 500 by 183.1 percentage points Trailed |
| 10Y | SCNI: down 100.0% S&P 500: up 319.6% −57.2% vs +15.4% a year | SCNI trailed the S&P 500 by 419.6 percentage points Trailed |
$10,000 invested in SCNI 10 years ago (Oct 14, 2016) would be worth about $2 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,964.
SCNI trailed the S&P 500 in all 7 periods.
| Period | SCNI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SCNI: down 50.5% S&P 500: up 1.2% | SCNI trailed the S&P 500 by 51.7 percentage points Trailed |
| 3M | SCNI: down 70.4% S&P 500: up 1.7% | SCNI trailed the S&P 500 by 72.1 percentage points Trailed |
| YTD | SCNI: down 89.4% S&P 500: up 11.9% | SCNI trailed the S&P 500 by 101.3 percentage points Trailed |
| 1Y | SCNI: down 94.8% S&P 500: up 15.5% | SCNI trailed the S&P 500 by 110.3 percentage points Trailed |
| Long term | ||
| 3Y | SCNI: down 99.0% S&P 500: up 75.0% −78.3% vs +20.5% a year | SCNI trailed the S&P 500 by 174.0 percentage points Trailed |
| 5Y | SCNI: down 100.0% S&P 500: up 71.2% −79.8% vs +11.4% a year | SCNI trailed the S&P 500 by 171.2 percentage points Trailed |
| 10Y | SCNI: down 100.0% S&P 500: up 258.1% −57.2% vs +13.6% a year | SCNI trailed the S&P 500 by 358.1 percentage points Trailed |
$10,000 invested in SCNI 10 years ago (Oct 14, 2016) would be worth about $2 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,813.
All-time high
$51,100.00
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since May 12, 2015.
Stock splits
3
Latest: 1-for-10 on . Share counts adjust after each split.
All 3 splits
- 1-for-10
- 1-for-10
- 1-for-10
Valuation
Financials
About Scinai Immunotherapeutics Ltd
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company with two complementary business units: In-house development of inflammation and immunology (I&I) biological products beginning with an innovative, de-risked, pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs; and a comprehensive CDMO service to help biotech companies bring their products to market efficiently and effectively by leveraging Scinai's GMP and non-GMP drug development and manufacturing capabilities for pre-clinical and clinical studies. Company website: www.scinai.com.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Israel
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
SCNI news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
SCNI stock FAQ
What is SCNI stock’s price today?
Scinai Immunotherapeutics (SCNI) traded at $0.75 at the close on , down $0.15 (16.54%) from the previous close of $0.90. Over the past 52 weeks it has traded between $0.73 and $15.50.
If you invested $1,000 in SCNI 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in SCNI on would be worth about $0 at the close on , a total return of −100.0%. The same $1,000 would be worth $0 if invested five years ago and $52 if invested one year ago. Past performance doesn’t predict future returns.
Does SCNI pay a dividend?
Scinai Immunotherapeutics hasn’t paid a dividend in the last twelve months.
What is SCNI’s 52-week high and low?
Over the past 52 weeks SCNI has traded as low as $0.73 and as high as $15.50. At $0.75 at the close on , it is 95.1% below that high and 2.8% above the low.
What is SCNI’s all-time high?
SCNI’s highest closing price was $51,100.00 on , adjusted for stock splits. At $0.75 at the close on , it is 100.0% below that record.
Has SCNI stock ever split?
Yes, three times: 1-for-10 on ; 1-for-10 on ; 1-for-10 on .
How has SCNI stock performed?
Including dividends and measured to the close on , SCNI has returned −89.4% so far this year and −94.8% over the past year, and −100.0% over five years (−79.8% a year). Over the same periods the S&P 500, measured by SPY, returned +12.8%, +16.8% and +83.1%. Past performance doesn’t predict future returns.
What sector and industry is Scinai Immunotherapeutics in?
Scinai Immunotherapeutics is in the Healthcare sector and the Biotechnology industry, and is headquartered in Israel.
What exchange does SCNI trade on?
Scinai Immunotherapeutics trades on the Nasdaq under the ticker symbol SCNI. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.